标题
Mutant p53: One, No One, and One Hundred Thousand
作者
关键词
-
出版物
Frontiers in Oncology
Volume 5, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2015-12-21
DOI
10.3389/fonc.2015.00289
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells
- (2015) Puyu Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
- (2015) Shuo Wei et al. NATURE MEDICINE
- A child with Li-Fraumeni syndrome: Modes to inactivate the second allele ofTP53in three different malignancies
- (2015) Brigitte Schlegelberger et al. PEDIATRIC BLOOD & CANCER
- Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
- (2015) Alla Polotskaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo
- (2015) Xingxing He et al. TUMOR BIOLOGY
- Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
- (2015) Madhusudhan Kollareddy et al. Nature Communications
- Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome
- (2015) Paul M. Neilsen et al. Oncotarget
- Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
- (2014) Patricia A.J. Muller et al. CANCER CELL
- Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
- (2014) Susann Weissmueller et al. CELL
- The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele
- (2014) Y Shetzer et al. CELL DEATH AND DIFFERENTIATION
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
- (2014) Giulio Di Minin et al. MOLECULAR CELL
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Pla2g16 phospholipase mediates gain-of-function activities of mutant p53
- (2014) S. Xiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting TopBP1 at a convergent point of multiple oncogenic pathways for cancer therapy
- (2014) Pinki Chowdhury et al. Nature Communications
- The Spectrum of Statin Therapy in Cancer Patients: Is There a Need for Further Investigation?
- (2013) Michael J. Gonyeau Current Atherosclerosis Reports
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Disarming mutant p53 oncogenic function
- (2013) Javier E. Girardini et al. PHARMACOLOGICAL RESEARCH
- HSP90 Inhibitors: Current Development and Potential in Cancer Therapy
- (2013) Katerina Sidera et al. Recent Patents on Anti-Cancer Drug Discovery
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
- (2013) Noriko Kobayashi et al. Journal of Ovarian Research
- A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer
- (2012) Cynthia X. Ma et al. BREAST CANCER RESEARCH AND TREATMENT
- Cell-type, Dose, and Mutation-type Specificity Dictate Mutant p53 Functions In Vivo
- (2012) Ming Kei Lee et al. CANCER CELL
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion
- (2012) Cynthia R Coffill et al. EMBO REPORTS
- Mutant p53 cooperates with ETS2 to promote etoposide resistance
- (2012) P. M. Do et al. GENES & DEVELOPMENT
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature
- (2012) Hilla Solomon et al. JOURNAL OF CELL SCIENCE
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
- (2012) W Yan et al. ONCOGENE
- Synthetic lethality of Chk1 inhibition combined with p53 and/or p21 loss during a DNA damage response in normal and tumor cells
- (2012) S Origanti et al. ONCOGENE
- A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
- (2011) Javier E. Girardini et al. CANCER CELL
- Multiple Stress Signals Activate Mutant p53 In Vivo
- (2011) Y.-A. Suh et al. CANCER RESEARCH
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
- (2011) Rosa Linda Messina et al. INTERNATIONAL JOURNAL OF CANCER
- Mutant p53 Disrupts MCF-10A Cell Polarity in Three-dimensional Culture via Epithelial-to-mesenchymal Transitions
- (2011) Yanhong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TopBP1 Mediates Mutant p53 Gain of Function through NF-Y and p63/p73
- (2011) K. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
- (2010) Perry Stambolsky et al. CANCER CELL
- The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs
- (2010) Silvia Di Agostino et al. CELL CYCLE
- Characterization of Functional Domains Necessary for Mutant p53 Gain of Function
- (2010) Wensheng Yan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
- (2009) J M R Lambert et al. ONCOGENE
- Peptide Aptamers Targeting Mutant p53 Induce Apoptosis in Tumor Cells
- (2008) E. Guida et al. CANCER RESEARCH
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
- (2008) F. M. Boeckler et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started